Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Lyra Therapeutics Inc (NASDAQ: LYRA) closed the day trading at $0.18 down -9.60% from the previous closing price of $0.20. In other words, the price has decreased by -$9.60 from its previous closing price. On the day, 1.1 million shares were traded. LYRA stock price reached its highest trading level at $0.199 during the session, while it also had its lowest trading level at $0.1818.
Ratios:
For a better understanding of LYRA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.64. In the meantime, Its Debt-to-Equity ratio is 1.71 whereas as Long-Term Debt/Eq ratio is at 1.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on May 07, 2024, Downgraded its rating to Hold and sets its target price to $0.50 from $10 previously.
On May 07, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $12 to $2.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LYRA now has a Market Capitalization of 11952576 and an Enterprise Value of -4349433. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.35 while its Price-to-Book (P/B) ratio in mrq is 0.58. Its current Enterprise Value per Revenue stands at -2.957 whereas that against EBITDA is 0.065.
Stock Price History:
Over the past 52 weeks, LYRA has reached a high of $6.79, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is -19.30%, while the 200-Day Moving Average is calculated to be -87.48%.
Shares Statistics:
Over the past 3-months, LYRA traded about 1.57M shares per day on average, while over the past 10 days, LYRA traded about 1293060 shares per day. A total of 65.46M shares are outstanding, with a floating share count of 54.79M. Insiders hold about 16.29% of the company’s shares, while institutions hold 46.47% stake in the company. Shares short for LYRA as of 1732838400 were 2202963 with a Short Ratio of 1.40, compared to 1730332800 on 2040864. Therefore, it implies a Short% of Shares Outstanding of 2202963 and a Short% of Float of 4.2.
Earnings Estimates
The company has 1.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$1.16 and -$1.39 for the fiscal current year, implying an average EPS of -$1.27. EPS for the following year is -$0.94, with 2.0 analysts recommending between -$0.86 and -$1.03.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for LYRA’s current fiscal year. The highest revenue estimate was $1.7M, while the lowest revenue estimate was $1.3M, resulting in an average revenue estimate of $1.52M. In the same quarter a year ago, actual revenue was $1.56M
